Vifor Pharma is an international specialty pharma company that researches, develops, produces and markets its own pharmaceutical products. The company has two main areas of focus:
- iron deficiency with and without anaemia
- as well as infectious diseases/OTX products.
The strategy also includes the support of Vifor Fresenius Medical Care Renal Pharma (VFMCRP) to broaden its position as leading player in nephrology.
- With its iron replacement products Ferinject®/Injectafer®, Venofer® and Maltofer®, Vifor Pharma is a leader in the treatment of iron deficiency, a widespread ailment around the world. The product portfolio is completed by Velphoro®, a new drug developed by Vifor Pharma, to effectively control phosphorus levels in the blood for patients with chronic kidney disease on dialysis. To gain rapid and direct access to the various international markets, Vifor Pharma works through its own sales affiliates as well as with partners.
- The immunostimulant products such as Broncho-Vaxom® and Uro-Vaxom® supplement the portfolio of Vifor Pharma and offer potential for expansion.